Go here to see the original:
Seer to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
Author Archives: Fredricko
Palisade Bio to Present at the H.C. Wainwright BIOCONNECT Virtual Conference and Biotech Showcase
Read more from the original source:
Palisade Bio to Present at the H.C. Wainwright BIOCONNECT Virtual Conference and Biotech Showcase
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
Go here to see the original:
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
Mindset Pharma Recaps 2021 Milestones and Highlights
See more here:
Mindset Pharma Recaps 2021 Milestones and Highlights
ProQR Announces Amendment to Convertible Debt Financing Agreement with Pontifax Ventures and Kreos Capital
Read more from the original source:
ProQR Announces Amendment to Convertible Debt Financing Agreement with Pontifax Ventures and Kreos Capital
Notification about final share buy-back
Excerpt from:
Notification about final share buy-back
Immunovant Provides Regulatory Update Regarding Initiation of Phase 3 Trial for Batoclimab in Myasthenia Gravis in the First Half of 2022
Gritstone Announces Presentations during Three Upcoming Investor Conferences
View original post here:
Gritstone Announces Presentations during Three Upcoming Investor Conferences
Repligen Corporation to Present at 40th Annual J.P. Morgan Healthcare Conference
Registration Now Open For Tribe Public’s Webinar Event "Addressing The Increasing Demand For Rare Cannabinoids" Featuring InMed’s…
Lotus Ventures Inc. Reports Fiscal 2021 Results
Go here to read the rest:
Lotus Ventures Inc. Reports Fiscal 2021 Results
BeyondSpring Announces Third Quarter 2021 Financial Results and Provides a Corporate Update
Madrigal Provides Update on Timeline for Topline Results from the Phase 3 MAESTRO-NAFLD-1 Clinical Trial of Resmetirom
Biofrontera Inc. announces reduction of Biofrontera AG shareholding to less than 50% through warrant exercises
Total number of shares and voting rights in Zealand Pharma at December 30, 2021
See the original post:
Total number of shares and voting rights in Zealand Pharma at December 30, 2021
Ocugen Partner, Bharat Biotech, Announces Positive Immunogenicity and Safety Data From COVAXIN™ (BBV152), COVID-19 Candidate Vaccine, in Children 2…
Akari Therapeutics, Plc Announces $6.0 Million Registered Direct Offering
Lexicon Submits New Drug Application for Sotagliflozin for the Treatment of Heart Failure in Adults With Type 2 Diabetes
Read more from the original source:
Lexicon Submits New Drug Application for Sotagliflozin for the Treatment of Heart Failure in Adults With Type 2 Diabetes
Mesoblast Provides Update Following Meeting With FDA’s OTAT on Remestemcel-L for Children With Acute Graft Versus Host Disease
MedMira Reports First Quarter Results FY2022
Visit link:
MedMira Reports First Quarter Results FY2022